Thakkar Radhika, Nalini M Rama, Jha Rohit K, Chaturvedi Mudita, Prathigudupu Raja S, Hemavathy S, Dayanithi B S
Graduate Medical Education (GME) Residency Program, Eastman Institute for Oral Health, University of Rochester, Rochester, NY, United States.
Department of Oral and Maxillofacial Surgery, GITAM Dental College and Hospital, Visakhapatnam, Andhra Pradesh, India.
J Pharm Bioallied Sci. 2024 Jul;16(Suppl 3):S2727-S2729. doi: 10.4103/jpbs.jpbs_299_24. Epub 2024 Jun 7.
Because of its high rates of morbidity and death, especially in its late stages, oral cancer poses a serious threat to world health. Even with improvements in surgical and chemotherapeutic techniques, advanced oral cancer is still difficult to treat and frequently has unfavorable results.
Information on demographics, tumor features, treatment options, and results were gathered from medical records. Patients were categorized according to whether they underwent surgery alone or adjuvant radiation treatment after initial surgical resection. For the survival analysis, Kaplan-Meier curves and Cox proportional hazards models were employed.
There were 150 patients in all, 75 in each group, who took part in the trial. Comparing adjuvant radiation to surgery alone resulted in considerably better overall survival ( < 0.001) and disease-free survival ( < 0.001). However, problems connected to the adjuvant radiation group affected a portion of the patient population.
In conclusion, patients with advanced oral cancer can improve their overall and disease-free survival with adjuvant radiation, a successful therapeutic option. To maximize results, nevertheless, cautious patient selection and effective management of treatment-related problems are crucial. To improve treatment algorithms and investigate cutting-edge therapeutic techniques for this difficult condition, further research is necessary.
口腔癌因其高发病率和死亡率,尤其是在晚期,对世界健康构成严重威胁。即使手术和化疗技术有所改进,晚期口腔癌仍然难以治疗,且常常产生不良后果。
从病历中收集有关人口统计学、肿瘤特征、治疗选择和结果的信息。根据患者在初次手术切除后是仅接受手术还是接受辅助放疗进行分类。对于生存分析,采用Kaplan-Meier曲线和Cox比例风险模型。
共有150名患者参与试验,每组75名。辅助放疗与单纯手术相比,总生存期(<0.001)和无病生存期(<0.001)均显著更好。然而,辅助放疗组的一些问题影响了部分患者群体。
总之,辅助放疗是晚期口腔癌患者提高总生存期和无病生存期的一种成功治疗选择。然而,为了使结果最大化,谨慎的患者选择和有效管理治疗相关问题至关重要。为了改进治疗方案并研究针对这种疑难病症的前沿治疗技术,还需要进一步研究。